Lancet Revises Editorial Policy Following Scandal Over Hydroxychloroquine Study
Three months ago, the prestigious medical journal The Lancet published, and then later retracted, a study on the use of hydroxychloroquine for COVID-19. The retraction was prompted by questions that were subsequently raised about the integrity of the data used for analysis from a database called Surgisphere, especially when it turned out that none of…
